Clinical Research Directory
Browse clinical research sites, groups, and studies.
Travoprost Intraocular Implant + iStent Infinite
Sponsor: Glaukos Corporation
Summary
Adult subjects with elevated intraocular pressure will be randomized to receive iStent infinite trabecular bypass system plus a travoprost intraocular implant or receive a sham procedure plus a travoprost intraocular implant and be followed for 12 months.
Official title: Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose® TR (Travoprost Intraocular Implant) in Conjunction With the Placement of iStent Infinite in Subjects With Open-angle Glaucoma or Ocular Hypertension
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
150
Start Date
2023-09-14
Completion Date
2028-02
Last Updated
2026-06-02
Healthy Volunteers
No
Conditions
Interventions
Travoprost Intraocular Implant
anchored intracameral implant containing travoprost
iStent infinite
Successful iStent infinite surgery
Sham procedure
Sham procedure (to mimic placement of an iStent infinite)
Locations (1)
Glaukos Clinical Study Site
Oklahoma City, Oklahoma, United States